BioGaia Pharma AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Subsidiary
- Established
- 1990-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.biogaiapharma.com
Clinical Trials
3
Active:1
Completed:2
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications
Phase 2
Completed
- Conditions
- Opioid-Induced Constipation
- Interventions
- Biological: Lactobacillus gasseri BGP345ABiological: Placebo
- First Posted Date
- 2021-11-24
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- BioGaia Pharma AB
- Target Recruit Count
- 14
- Registration Number
- NCT05133076
- Locations
- 🇫🇷
Groupe hospitalier Saint-Joseph, Paris, France
🇫🇷CHU d'Amiens, Amiens, France
🇫🇷CHU DE NANTES (Hôpital Nord Laennec), Saint- Herblain, France
A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis
- First Posted Date
- 2021-11-12
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- BioGaia Pharma AB
- Target Recruit Count
- 35
- Registration Number
- NCT05118919
- Locations
- 🇸🇪
Department of Gastroenterology and Hepatology, Linköping University Hospital, Linköping, Sweden
🇸🇪Gastroenterology Department, Danderyds Hospital, Stockholm, Sweden
🇸🇪Gastroenterology Department, Ersta Hospital, Stockholm, Sweden
News
No news found